Merck, Simcere team up in China

Merck has inked a joint venture partnership with China's Simcere Pharmaceutical Group. In addition to vaccines, which the two companies already market together, Simcere and Merck will market and manufacture cardiovascular and metabolic drugs. The joint venture also covers some development work, though Merck's release didn't provide any details about that aspect of the deal. Report

Suggested Articles

Loh joins the computational chemistry specialist after a two-year stint at Kymera Therapeutics.

The $3 billion funding boost includes an additional $350 million for targeted Alzheimer’s research.

Less than two years after taking the reins from founding chief Rusty Williams, Five Prime Therapeutics CEO Aron Knickerbocker is exiting the company.